IHS Chemical Week

Regions :: Western Europe :: Germany

Merck KGaA appoints Simon Sturge as new head of biosimilars unit

3:19 AM MST | February 20, 2014 | Deepti Ramesh

Merck KGaA says that Simon Sturge will join the company from Boehringer Ingelheim (Ingelheim, Germany) effective 1 March 2014, to head the biosimilars unit. The Simon Sturge. biosimilars unit is part of Merck’s pharmaceutical businesses alongside with Merck Serono (Darmstadt, Germany), the consumer health division and the Allergopharma unit. Sturge, in his new role, will report to Stefan Oschmann, member of Merck’s executive board and responsible for the company’s pharmaceutical businesses. Sturge succeeds Thierry Hulot, who created the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa